GCM
MRTX

Graham Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Graham Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,256
Closed -$2.04M – 1425
2022
Q3 		$2.04M Buy
+29,256
New +$2.04M 0.08% 215